These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 486417)
1. Quantitative assessment of the noncovalent inhibition of sickle hemoglobin gelation by phenyl derivatives and other known agents. Behe MJ; Englander WS Biochemistry; 1979 Sep; 18(19):4196-201. PubMed ID: 486417 [TBL] [Abstract][Full Text] [Related]
2. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors. Noguchi CT; Ackerman S; DiMaio J; Schiller PW; Schechter AN Mol Pharmacol; 1983 Jan; 23(1):100-3. PubMed ID: 6865893 [TBL] [Abstract][Full Text] [Related]
3. Noncovalent inhibitors of sickle hemoglobin gelation: effects of tetrasubstituted ammonium salts. Mazhani L; Kim BC; Poillon WN Hemoglobin; 1984; 8(2):129-36. PubMed ID: 6469693 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of sickle hemoglobin gelation by amino acids and related compounds. Noguchi CT; Schechter AN Biochemistry; 1978 Dec; 17(25):5455-9. PubMed ID: 728408 [TBL] [Abstract][Full Text] [Related]
13. Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease. Votano JR; Altman J; Wilchek M; Gorecki M; Rich A Proc Natl Acad Sci U S A; 1984 May; 81(10):3190-4. PubMed ID: 6587344 [TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationships of inhibitors of immune complex-induced inflammation: 1-phenyl-3-aminopyrazoline derivatives. Kim KH; Martin YC; Norris B; Young PR; Carter GW; Haviv F; Walters RL J Pharm Sci; 1990 Jul; 79(7):609-13. PubMed ID: 2144591 [TBL] [Abstract][Full Text] [Related]
15. QSAR and molecular shape analysis of aryl-substituted alanine analogs as antigelling agents. Yuan CJ; Hopfinger AJ; Johnson ME J Theor Biol; 1989 Nov; 141(1):41-52. PubMed ID: 2634159 [TBL] [Abstract][Full Text] [Related]
17. Edge-to-face CH/pi interaction between ligand Phe-phenyl and receptor aromatic group in the thrombin receptor activation. Matsushima A; Fujita T; Nose T; Shimohigashi Y J Biochem; 2000 Aug; 128(2):225-32. PubMed ID: 10920258 [TBL] [Abstract][Full Text] [Related]
18. Effect of other hemoglobins on gelation of sickle cell hemoglobin. Sunshine HR Tex Rep Biol Med; 1980-1981; 40():233-50. PubMed ID: 6172866 [No Abstract] [Full Text] [Related]
19. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives. Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121 [TBL] [Abstract][Full Text] [Related]
20. The physical chemistry of the gelation of sickle hemoglobin. Briehl RW Tex Rep Biol Med; 1980-1981; 40():207-20. PubMed ID: 6275565 [No Abstract] [Full Text] [Related] [Next] [New Search]